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Abstract
Introduction:  The  recently-proposed  Bethesda  reporting  system  has  offered  clinical  recommen-
dations for  each  category  of  reported  thyroid  cytology,  including  repeated  ﬁne-needle  aspiration
(FNA) for  non-diagnostic  and  atypia/follicular  lesions  of  undetermined  signiﬁcance,  but  there
are no  sound  indications  for  repeated  examination  after  an  initial  benign  exam.
Objective:  To  investigate  the  clinical  validity  of  repeated  FNA  in  the  management  of  patients
with thyroid  nodules.
Method:  The  present  study  evaluated  412  consecutive  patients  who  had  repeated  aspiration
biopsies  of  thyroid  nodules  after  an  initial  non-diagnostic,  atypia/follicular  lesion  of  undeter-
mined signiﬁcance,  or  benign  cytology.
Results:  The  majority  of  patients  were  female  (93.5%)  ranging  from  13  to  83  years.  Non-
diagnostic  cytology  was  the  most  common  indication  for  a  repeated  examination  in  237  patients
(57.5%), followed  by  benign  (36.8%),  and  A/FLUS  (5.6%)  cytology.  A  repeated  examination
altered the  initial  diagnosis  in  70.5%  and  78.3%  of  the  non-diagnostic  and  A/FLUS  patients,
respectively,  whereas  only  28.9%  of  patients  with  a  benign  cytology  presented  with  a  different
diagnosis  on  a  sequential  FNA.
Conclusions:  Repeat  FNA  is  a  valuable  procedure  in  cases  with  initial  non-diagnostic  or  A/FLUS
cytology, but  its  routine  use  for  patients  with  an  initial  benign  examination  appears  to  not
increase the  expected  likelihood  of  a  malignant  ﬁnding.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Repetic¸ão  da  punc¸ão por  agulha  ﬁna  para  o  diagnóstico  e  seguimento  de  nódulos  de
tireoide
Resumo
Introduc¸ão:  A  classiﬁcac¸ão  de  Bethesda  para  relatórios  citológicos  de  tireoide  oferece
recomendac¸ões clínicas  para  cada  categoria  diagnóstica,  incluindo  a  repetic¸ão  do  exame  de
punc¸ão para  exames  citológicos  não  diagnósticos  (ND)  e  atipia/lesão  folicular  de  signiﬁcado
indeterminado  (A/FLUS).  Todavia,  a  repetic¸ão  da  punc¸ão  para  pacientes  com  exame  citológico
inicial benigno  ainda  é  discutida.
Objetivo:  Investigar  a  validade  da  punc¸ão  repetida  para  o  manejo  de  pacientes  com  nódulos
tireoidianos.
Método: Estudo  longitudinal  histórico  avaliando  412  pacientes  consecutivos  com  biópsias  aspi-
rativas repetidas  de  nódulos  da  tireoide  após  exame  inicial  ND,  A/FLUS,  ou  benigno.
Resultados:  A  citologia  não  diagnóstica  foi  a  indicac¸ão  mais  comum  para  um  exame  repetido
em 237  pacientes  (57,5%),  seguida  por  citologia  inicial  benigna  (36,8%)  e  A/FLUS  (5,6%).  Um
exame repetido  alterou  o  diagnóstico  inicial  de  70,5%  e  78,3%  dos  pacientes  com  citologia  inicial
não diagnóstica  e  A/FLUS,  respectivamente,  enquanto  apenas  28,9%  dos  pacientes  com  uma
citologia inicial  benigna  apresentaram  um  diagnóstico  diferente  em  uma  punc¸ão  sequencial.
Conclusões:  Repetir  a  punc¸ão  aspirativa  é  um  procedimento  válido  para  pacientes  com  citolo-
gia inicial  não  diagnóstica  ou  atipia/lesão  folicular  de  signiﬁcado  indeterminado,  mas  seu  uso
rotineiro em  pacientes  com  exame  inicial  benigno  parece  não  aumentar  a  probabilidade  de
malignidade  para  este  grupo.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
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Introduction
Thyroid  nodules  are  common.  Current  data  suggest  that
nodules  are  present  in  5%  to  10%  of  women  and  1%  to
2%  of  adult  men.1--3 Furthermore,  nodules  have  been  inci-
dentally  diagnosed  via  ultrasound  scans  in  up  to  67%  of
elderly  females.4,5 It  is  believed  that  5%  to  15%  of  these
nodules  are  malignant.6 Clinical  and  diagnostic  ﬁndings  are
warranted  to  differentiate  patients  at  risk  for  malignancy
who  require  further  workup.  This  enhanced  diagnosis  likely
contributes  to  the  increase  in  surgically  treated  thyroid  can-
cers  over  the  last  decades,  which  affect  3.5--8.5/100,000
of  women  and  2.3/100,000  of  men.7,8 Fine-needle  aspira-
tion  (FNA)  biopsy  has  proved  to  be  a  valuable  tool  for  the
evaluation  of  these  nodules,  with  a  diagnostic  accuracy
of  approximately  97%  and  pivotal  clinical  implications.9,10
In  general,  FNA  biopsy  is  recommended  for  solid  hypoe-
choic  nodules  greater  than  1  cm  in  largest  dimension,  mixed
solid/cystic  nodules  greater  than  2  cm,  and  microcentimeter
nodules  with  suspect  ultrasound  features,  such  as  micro-
calciﬁcations  and  irregular  borders.  In  addition,  FNA  is
warranted  for  patients  at  high  risk  for  thyroid  cancer,  includ-
ing  those  with  a  familial  history  for  this  cancer  or  multiple
endocrine  neoplasia,  and  exposure  to  ionizing  radiation
in  early  life.  The  recently  described  Bethesda  system  for
reporting  thyroid  cytopathology  outlines  six  categories  with
correlating  clinical  recommendations  for  each  category.  A
repeated  FNA,  within  three  to  six  months,  is  suggested  for
initial  non-diagnostic  examinations  and  also  for  patients
with  atypia/folicullar  lesions  of  undetermined  signiﬁcance
(A/FLUS).11--13 A  sequential  exam  is  not  routinely  recom-
mended  for  patients  with  initial  benign  cytology,  as  most  are
judiciously  followed-up  with  sequential  clinical  examination
a
i
s
rireitos  reservados.
nd  imaging.  Despite  this  practice,  some  data  suggest  that
epeated  FNA  should  also  be  considered  for  patients  with
n  initial  benign  cytology  in  order  to  decrease  the  risk  of
alse  negatives  and  conﬁrm  the  benign  features  of  these
odules.14--20 Therefore,  the  present  study  sought  to  eval-
ate  the  indications  and  validity  of  repeated  FNA  in  the
anagement  of  patients  with  thyroid  nodules.
aterials and methods
his  was  a  retrospective  cohort  study  of  568  consecutive
atients  who  had  repeated  aspiration  biopsies  of  thyroid
odules  evaluated  in  a  single  center  between  January  of
998  and  December  of  2010.  Due  to  differences  in  thyroid
ytology  reporting  over  the  study  period,  all  cytological
esults  were  updated  according  to  the  2010  Bethesda  sys-
em  for  reporting  thyroid  cytology.  All  patients  had  an  initial
xamination  classiﬁed  as  non-diagnostic,  benign,  or  A/FLUS,
nd  at  least  one  more  repeated  FNA  within  a  maximum
nterval  of  36  months  between  aspirations,  in  addition  to
o  signiﬁcant  clinical  or  radiological  changes  in  the  previ-
usly  evaluated  dominant  or  single  nodule.  Patients  with  a
epeated  FNA  within  a time  frame  greater  the  previously
entioned,  and  those  with  a  cytology  report  of  follicu-
ar  neoplasm,  suspected  for  malignancy  or  conﬁrmed  as
alignant,  were  excluded.  Descriptive  and  comparative
tatistical  analyses  were  performed  using  SPSS  13.0  for
indows® and  sought  to  assess  the  possibility  of  repeated
spiration  to  alter  the  initial  diagnosis,  with  a  particular
nterest  in  the  rate  of  suspect/malignant  ﬁndings  on  sub-
equent  FNA  stratiﬁed  by  initial  cytological  diagnosis.  The
esults  were  expressed  as  frequencies  and  percentages,
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Table  1  Cytology  results  for  initial  versus  repeated  ﬁne-
needle  aspiration  (FNA).
FNA  2  FNA  1
Non-diagnostic  benign  A/FLUS
ND  70  19  5
29.5% 12.5%  21.7%
B 106  108  10
44.7% 71.1% 43.5%
A/FLUS  25  13  5
10.5% 8.6%  21.7%
FN 24  7  2
10.1% 4.6%  8.7%
S/M 12  5  1
5.1% 3.3%  4.3%
= FNA  1  70  108  5
29.5% 71.1%  21.7%
/= FNA  1  167  44  18
70.5%  28.9%  78.3%
Total 237  152  23
FNA 1, initial; FNA 2, repeated; ND, non diagnostic; B, benign;
A/FLUS, atypia or follicular lesion of undetermined signiﬁcance;
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Table  2  Probability  of  different  repeated  ﬁne-needle  aspi-
ration  cytology  report  between  groups.
FNA  1  pa
ND  ×  B  <0.001
ND ×  A/FLUS 0.630
B  ×  A/FLUS  <0.001
ND, Non diagnostic; A/FLUS, atypia or follicular lesion of unde-
termined signiﬁcance; B, benign.
a Fisher’s exact test; p < 0.008.
Table  3  Comparison  of  the  risk  of  malignancy  for  a  repeat
ﬁne-needle  aspiration  between  groups.
Malignancy  rates  compared  pa
ND  ×  B  0.457
ND ×  A/FLUS  1.000
B ×  A/FLUS  0.576
ND, non diagnostic; A/FLUS, atypia or follicular lesion of unde-
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FFN, follicular neoplasia; S/M, suspicious/malignant cytology; =,
similar FNA1; /= , different FNA1.
nd  Fisher’s  exact  test  was  used  to  compare  the  ratings
f  observed  results  between  categories.  This  study  was
pproved  by  the  ethics  committee  of  the  institution  (CEP
00046).
esults
he  ﬁnal  analysis  included  412  patients  ranging  from  13  to
3  years  of  age  (mean  49.3  years).  The  majority  of  patients
ere  female  (93.5%).  The  mean  interval  between  initial
nd  sequential  examinations  was  10.8  months  for  the  entire
ohort.  However,  this  interval  varied  from  6.3  months  for
on-diagnostic  cytology  to  18.1  months  and  13.8  months  for
enign  and  A/FLUS  cytology,  respectively.  A  non-diagnostic
ytology  was  the  most  common  indication  for  a  repeated
NA  in  237  patients  (57.5%),  followed  by  benign  (36.8%),  and
/FLUS  (5.6%)  at  initial  FNA  (Table  1).  A  repeated  examina-
ion  altered  the  initial  diagnosis  in  70.5%  and  78.3%  of  the
on-diagnostic  and  A/FLUS  patients,  respectively,  whereas
nly  28.9%  of  patients  with  a  benign  cytology  presented
ith  a  different  diagnosis  on  a  sequential  FNA.  This  dif-
erence  between  groups  was  signiﬁcant,  as  patients  with
nitial  benign  cytology  had  a  much  higher  chance  of  a
imilar  result  on  a  sequential  examination  (Table  2).  No
igniﬁcant  difference  was  observed  in  the  occurrence  of  a
epeated  FNA  showing  a  suspect/malignant  cytology  for  a
on-diagnostic  (5.1%),  benign  (3.3%),  or  A/FLUS  (4.3%)  initial
xam  (Table  3).
o
f
w
etermined signiﬁcance; B, benign.
a Fisher’s exact test; p < 0.008.
Surgical  treatment  outcome  data  was  obtained  from
6.6%  (63/237)  of  patients  with  an  initial  non-diagnostic
NA,  and  for  21.7%  (5/23)  of  patients  with  an  A/FLUS  cytol-
gy,  whereas  only  14.5%  (22/152)  of  patients  with  an  initial
enign  diagnosis  had  surgery.  Histologic  data  are  summa-
ized  in  Table  4.
iscussion
linical  and  incidental  ﬁndings  of  thyroid  nodules  have
ecome  common,  mainly  due  to  increased  awareness  of  this
ondition  and  readily-available  high  resolution  ultrasound
iagnostic  techniques.  Most  of  these  nodules  are  benign,
ith  limited  surgical  indications.  Obviously,  it  would  be  ideal
o  operate  only  those  patients  with  malignant  tumors  and
hose  whose  clinical  symptoms  required  surgical  manage-
ent.  The  use  of  FNA  for  thyroid  cytology  dates  back  to
he  early  1950s,  with  the  goal  of  identifying  nodules  with
n  increased  risk  for  malignancy.  FNA  has  gradually  evolved
s  a  key  diagnostic  tool  and  is  responsible  for  an  increase
f  surgically  treated  thyroid  cancers;  at  present,  50%  of
hyroidectomies  are  due  to  malignant  tumors,  whereas  this
ate  was  less  than  14%.21 FNA  cytology  reports  based  on  the
ecently  proposed  Bethesda  system  are  associated  with  sen-
itivity,  speciﬁcity,  and  diagnostic  accuracy  rates  of  97%,
0.7%,  and  68.8%,  respectively.22 Despite  these  ﬁgures,  thy-
oid  cytology  may  be  affected  by  non-diagnostic  specimens
n  approximately  10%  of  cases,23 and  is  particularly  challeng-
ng  A/FLUS  cases.
Non-diagnostic  FNA  was  the  most  common  indication  for
 repeated  examination  in  this  series,  with  70.5%  result-
ng  in  a  different  diagnosis  from  the  ﬁrst  cytology.  It  is
nteresting  to  note  that  44.7%  of  the  initial  non-diagnostic
NA  were  re-classiﬁed  as  a  Bethesda  2  (benign  cytol-
gy),  allowing  for  non-surgical  management  and  clinical
ollow-up  when  appropriate,  whereas  only  5.1%  presented
ith  a second  exam  that  was  suspect/malignant.  Furlan
t  al.24 also  observed  that  100%  of  their  patients  with  initial
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Table  4  Histological  outcome  according  to  initial  ﬁne-needle  aspiration  cytology.
Outcome
P1  Benign  Malignant
Non-diagnostic Nodular  hyperplasia  --  40  Papillary  carcinoma  --  9
Hashimoto’s  thyroiditis  --  6  Hurthle  cell  carcinoma  --  2
Hurthle  cell  adenoma  --  4  (17.5%)
Follicular  adenoma  --  2
(82.5%)
Benign Nodular  hyperplasia  --  14 Papillary  carcinoma  --  5
Hashimoto’s  thyroiditis  -- 3 (22.7%)
(77.3%)
A/FLUS Follicular  adenoma  --  1  Papillary  carcinoma  --  2
Nodular hyperplasia  --  2  (40%)
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P1, initial ﬁne-needle aspiration cytology; A/FLUS, atypia or follic
non-diagnostic  cytology  were  re-classiﬁed  into  a  different
Bethesda  category  in  a  sequential  FNA.  A  decrease  in  the
percentage  of  non-diagnostic  results  was  also  observed  by
Orija  et  al.,25 who  found  that  sequential  FNA  provided
a  diagnosis  in  up  to  60%  of  these  cases.  Therefore,  the
Bethesda  recommendation  for  a  repeat  exam  after  three
to  six  months  after  the  ﬁrst  FNA  is  supported.  Coorough
et  al.26 also  observed  that  a  repeat  FNA  yielding  another
non-diagnostic  ﬁnding  had  twice  the  chance  of  presenting
with  carcinoma  at  ﬁnal  histology,  compared  to  a  5%  risk  of
malignancy  in  patients  who  had  a  diagnostic  cytology  prior  to
surgical  intervention.  The  present  study  included  63  patients
with  an  initial  non-diagnostic  cytology  who  underwent  sur-
gical  resection,  and  observed  that  17.5%  of  them  had  a
malignant  tumor  at  ﬁnal  pathology.  These  results  are  similar
to  those  of  Jo  et  al.,27 who  evaluated  a  group  of  57  non-
diagnostic  thyroid  aspirates  followed  by  surgical  resection
and  observed  a  20%  risk  of  malignancy  after  a  non-diagnostic
FNA,  which  would  favor  the  need  for  a  repeated  FNA  for  this
group  of  patients.  The  Bethesda  reporting  system  states  that
a  repeat  FNA  might  also  be  considered  for  A/FLUS  lesions,
but  the  beneﬁt  of  this  approach  is  yet  to  be  fully  captured.
In  the  present  study,  it  was  observed  that  5.6%  of  the
repeated  FNA  were  due  to  a  A/FLUS  cytology,  which  is  con-
sistent  with  an  expected  7%  rate  of  A/FLUS,13 and  43.5%
of  these  patients  were  classiﬁed  as  a  Bethesda  2  (benign
cytology)  in  a  sequential  FNA,  whereas  only  21.7%  persisted
as  A/FLUS.  These  ﬁgures  are  similar  to  those  reported  by
Chen  et  al.28 who  examined  26  patients  with  A/FLUS  nod-
ules  and  had  a  repeated  FNA  that  was  benign  in  42.3%  of
cases,  whereas  23.07%  persisted  as  A/FLUS.  Although  their
incidence  of  suspicious  for  malignancy  was  15.38%,  which
is  three  times  higher  than  the  4.3%  rate  observed  in  the
present  study,  these  differences  are  reasonable  as  the  true
incidence  of  malignancy  for  A/FLUS  is  still  unknown,  and
a  5%  to  15%  malignant  rate  is  an  acceptable  range  of  vari-
ability.  The  use  of  repeat  FNA  for  A/FLUS  lesions  has  also
proved  to  be  a  cost-effective  strategy  when  compared  to
a  standard  diagnostic  lobectomy.29 Despite  these  ﬁndings,
roughly  60%  of  patients  who  have  an  initial  A/FLUS  cytol-
ogy  are  still  referred  for  surgery  without  a  sequential  FNA,24
and  this  approach  is  expected  to  change  with  increased
e
c
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elesion of undetermined signiﬁcance.
ompliance  with  the  Bethesda  reporting  system  recommen-
ations.  In  the  present  study,  it  was  observed  that  40%  of
urgically  treated  patients  with  an  initial  A/FLUS  cytology
ad  a  malignant  tumor  diagnosed  at  histology.  These  ﬁgures
orrelate  with  those  of  Vander  Laann  et  al.,30 who  found  a
alignant  diagnosis  in  41%  to  43%  of  patients  after  a  single
r  consecutive  A/FUS  FNA,  respectively.  However,  any  fur-
her  consideration  regarding  the  relative  risk  of  malignancy
f  patients  with  A/FLUS  cytology  and  its  correlation  to  his-
ological  ﬁndings  was  beyond  the  objective  of  this  study  and
ould  be  limited  by  the  small  number  of  patients  included.
There  is  also  an  ongoing  debate  whether  patients  with
enign  cytology  may  also  beneﬁt  from  routine  repeat  FNA  to
educe  the  risk  of  false  negative  results.  Some  authors  have
hown  that  approximately  90%  to  98%  of  patients  with  an
nitial  benign  diagnosis  will  not  change  after  multiple  FNAs,
nd  concluded  that  routine  repeated  examinations  should
ot  be  considered  for  all  patients.17,31--33 It  has  been  found
hat  the  rates  of  change  for  suspicious/malignant  lesions  for
epeated  FNA  after  an  initial  benign  cytology  range  from
.5%  to  5%.  Orlandi  et  al.34 evaluated  patients  with  benign
odular  disease  and  suggested  that  at  least  three  sequen-
ial  FNAs  would  be  required  for  the  diagnosis  to  change  to
alignant  in  2.25%  of  cases,  considering  that  97.7%  of  the
xaminations  maintained  the  same  benign  cytological  pat-
ern  after  two  to  six  repeated  FNAs.  These  ﬁndings  were
imilar  to  those  of  Illouz  et  al.,35 in  which  86%  of  patients
ho  presented  with  suspicious/malignant  changes  after  a
epeated  FNA  for  benign  cytology  required  at  least  three
equential  exams  for  that  change  to  be  observed.  These
bservations  have  led  some  authors  to  favor  repeat  FNA  for
ll  patients  with  benign  nodular  goiters.36--38 In  the  present
tudy,  it  was  observed  that  3.3%  of  the  initially-benign  FNAs
ere  reported  as  suspicious/malignant  cytology  after  a  sin-
le  sequential  exam  and  these  were  the  only  patients  to
resent  a positive  histologic  ﬁnding  for  malignancy  at  sur-
ical  histology.  Furthermore,  the  projected  likelihood  of
alignancy  for  patients  with  an  initial  benign  FNA,  consid-
ring  the  observed  risk  of  malignancy  after  surgery  for  each
ytological  report  on  sequential  exam,  would  increase  for
.5%.  These  ﬁgures  are  not  signiﬁcantly  higher  than  the
xpected  5%  to  15%  rate  of  malignancy  for  any  solid  nodule.
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326  
t  is  interesting  to  note  that  at  least  91.5%  of  patients  with
n  initial  benign  cytologic  report  would  avoid  unnecessary
iagnostic  surgery  as  a  sequential  FNA  alone  would  not  sig-
iﬁcantly  increase  the  likelihood  of  a  malignancy  report.
his  is  also  supported  by  the  ﬁndings  of  Rosario  et  al.39
uggesting  that  suspicious  ultrasonographic  characteristics
such  as  microcalciﬁcation,  hypoechogenicity,  irregular  mar-
ins,  and  predominantly  central  ﬂow)  could  be  used  as  a
riterion  to  select  those  patients  with  an  initial  benign  cytol-
gy  that  would  beneﬁt  from  a  repeat  exam,  since  17%  of
atients  with  these  ﬁndings  would  present  with  a  malignant
hange  in  a  sequential  FNA  compared  to  0.5%  to  5%  malig-
ant  changes  whether  a  routine  repeat  FNA  was  offered  to
ll  patients  with  a  benign  cytology.
onclusion
epeat  FNA  is  a  valuable  procedure  in  cases  with  initial  non-
iagnostic  or  A/FLUS  cytology,  providing  information  that
ight  have  implications  regarding  clinical  follow-up  versus
urgical  intervention.
Its routine  use  for  the  follow-up  of  all  patients  with  an  ini-
ial  benign  examination  seems  not  to  increase  the  expected
ikelihood  of  a  malignant  lesion  and  should  likely  be  used  for
elected  cases.
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